Clearwater International advises i2i on its sale to IG&H
Clearwater International has advised i2i, a specialist data-analysis organisation in the field of healthcare effectiveness, on its sale to IG&H, a leading Netherlands based consulting and technology company. With this acquisition, IG&H strengthens its services in the healthcare industry.
i2i is a unique player in the Dutch healthcare market, specialising in healthcare effectiveness analysis. Across 10 years, the company has delivered significant social value to the Dutch healthcare system and is a Trusted Third-Party (TTP) for health insurers and institutions. i2i uses data to analyse effectiveness and quality of care in hospitals and elderly care institutions, identifying areas for improvement, which lead to the implementation of effective changes.
Active in the healthcare sector since 2005, IG&H is a leading consulting and technology company specialising in retail, financial services, and healthcare. The business is able to realise complex transformations that keep healthcare patient-centered, affordable, and accessible. IG&H combines sector knowledge with digital transformation and technology competencies, offering fast, flexible, and cost-effective solutions through low-code platforms. With over 400 professionals in Europe, the company is officially recognised as a Great Place to Work.
i2i will become an independent subsidiary of IG&H, retaining its own position and direct relationship as a contracting party for health insurers and healthcare providers. The company will also continue to fully function as a TTP.
-
Clearwater Advisers
Adviser to i2i on its sale to IG&H
View more
Clearwater Advisers
